4/9
05:17 pm
vrca
Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting [Yahoo! Finance]
High
Report
Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting [Yahoo! Finance]
4/9
04:05 pm
vrca
Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting
High
Report
Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting
4/9
06:24 am
vrca
Verrica Pharmaceuticals (VRCA) was downgraded by Zacks Research from "hold" to "strong sell".
Low
Report
Verrica Pharmaceuticals (VRCA) was downgraded by Zacks Research from "hold" to "strong sell".
4/6
08:15 am
vrca
Verrica Pharmaceuticals to Participate in the 25th Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
Medium
Report
Verrica Pharmaceuticals to Participate in the 25th Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
4/6
08:00 am
vrca
Verrica Pharmaceuticals to Participate in the 25th Annual Needham Virtual Healthcare Conference
Medium
Report
Verrica Pharmaceuticals to Participate in the 25th Annual Needham Virtual Healthcare Conference
3/20
07:42 pm
vrca
VRCA Investors Have the Opportunity to Join Investigation of Verrica Pharmaceuticals Inc. with the Schall Law Firm
High
Report
VRCA Investors Have the Opportunity to Join Investigation of Verrica Pharmaceuticals Inc. with the Schall Law Firm
3/20
09:09 am
vrca
VRCA Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. – VRCA
Medium
Report
VRCA Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. – VRCA
3/19
02:15 pm
vrca
Verrica Pharmaceuticals Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. – VRCA
Low
Report
Verrica Pharmaceuticals Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. – VRCA
3/11
08:32 am
vrca
Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
High
Report
Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/11
08:00 am
vrca
Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
High
Report
Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
3/11
07:19 am
vrca
Verrica Pharmaceuticals (VRCA) was downgraded by Zacks Research from "strong-buy" to "hold".
Low
Report
Verrica Pharmaceuticals (VRCA) was downgraded by Zacks Research from "strong-buy" to "hold".
3/5
08:00 am
vrca
Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 11, 2026
Low
Report
Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 11, 2026
2/23
08:13 am
vrca
Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
Low
Report
Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
2/23
08:00 am
vrca
Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference
Low
Report
Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference
2/12
08:00 am
vrca
Verrica Pharmaceuticals Appoints Chris Chapman as Chief Commercial Officer
Medium
Report
Verrica Pharmaceuticals Appoints Chris Chapman as Chief Commercial Officer
2/9
08:00 am
vrca
Verrica Pharmaceuticals Announces Launch of YCANTH® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical
Medium
Report
Verrica Pharmaceuticals Announces Launch of YCANTH® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical
2/7
02:07 am
vrca
Verrica Pharmaceuticals (NASDAQ:VRCA) was downgraded by analysts at
Wall
Medium
Report
Verrica Pharmaceuticals (NASDAQ:VRCA) was downgraded by analysts at
Wall
1/17
01:11 am
vrca
Verrica Pharmaceuticals (NASDAQ:VRCA) was upgraded by analysts at
Wall S
Medium
Report
Verrica Pharmaceuticals (NASDAQ:VRCA) was upgraded by analysts at
Wall S